Adrian Bot

Adrian Bot

Company: Capstan Therapeutics

Job title: CSO


Fireside Chat: Unveiling the Challenges that Arise in Scaling-Up from Pre-Clinical to Early Clinical Development 3:15 pm

Understanding what models and data may be required to progress towards the clinic Hearing about challenges encountered in scaling up to plan for more streamlined processes in the future Discovering the bottlenecks that have been faced in scaling up manufacturing to plan for potential challenges aheadRead more

day: Conference Day Two

Targeted mRNA-LNPs for Tunable Engineering of the Immune System 9:30 am

Describing the advantages and challenges presented by in vivo reprogramming of the immune system using non-cell based and non-viral based approaches Revealing the type and size of payload that can be delivered using LNPs to gain insights into the utilization of this technology Discussing the scalability, cost, and manufacturing of non-viral vectors such as LNPs…Read more

day: Conference Day Two

Industry Leader’s Fireside Chat: Supercharging In Vivo as the Frontier of Cell Therapy & Comparing to Ex Vivo 9:00 am

Accentuating the bottlenecks of ex vivo therapies, such as the need for costly manufacturing processes and limited access, to consider the need to move towards a new engineering technique Championing in vivo therapies by highlighting the solutions they could bring to the ex vivo cell therapy and gene editing field Reaffirming the shift of interest…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.